Yemparala
Krishna P. Yemparala, Irving, TX US
Patent application number | Description | Published |
---|---|---|
20120130780 | PROMOTION ANALYZER SYSTEM - A method performed by a server device, may include receiving information about a customer order, associated with a particular service or product provider, from an ordering system; determining whether the customer order is eligible for a promotion based on the received information where the promotion includes a reward to a customer for placing the customer order; and requesting balance information associated with the customer order from a billing system, when the customer order is eligible for the promotion. The method may further include receiving a balance amount, associated with the customer order, from the billing system; determining whether the balance amount is less than a balance threshold; and sending a message to a fulfillment system to fulfill the promotion, when the balance amount is less than the balance threshold. | 05-24-2012 |
Krishna Prasad Yemparala, Irving, TX US
Patent application number | Description | Published |
---|---|---|
20130013630 | LIVE DASHBOARD - A computing device receives a request for data, the request including criteria for data requested to be provided to the client device. Via a service configured to retrieve the requested data, at least some of the criteria are transmitted to a staging data store that includes transactional data. Via the service, data relevant to at least some of the criteria transmitted to the staging data store is received from the staging database. The data received from the staging database is stored in a data structure included in the computing device. At least some of the data stored in the data structure is transmitted to a client device. | 01-10-2013 |
Vijaya Phani Kumar Yemparala, Mumbai IN
Patent application number | Description | Published |
---|---|---|
20120190651 | ANTI-INFLAMMATORY COMPOUNDS - This invention relates to novel compounds obtained by fermentation of Myxobacteria strain (PM0670013/MTCC 5570). The present invention further relates to the processes for the production of the novel anti-inflammatory compounds, to the culture no. PM0670013 (MTCC 5570), and to pharmaceutical compositions containing compounds of the present invention as an active ingredient and its use in medicines for the treatment of inflammatory diseases or disorders mediated by proinflammatory cytokines such as Tumor Necrosis Factor-alpha (TNF-α) and/or interleukins such as IL-6, having anti-inflammatory activity The invention also includes all stereoisomeric forms of compounds of the present invention. | 07-26-2012 |